ArticleCancer2024

Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.

Karen L Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.